The 20 Best Infant Hyperglycemia Doctors Near Me in Ann Arbor, MI

Dr. Lynn Ang is currently a Clinical Associate Professor in the Metabolism, Endocrinology, and Diabetes Division, Internal Medicine Department at University of Michigan. Dr. Ang is one of the principle attending physicians for the Diabetes Transition Program. Dr. Ang’s clinical and research interests are in the fields of implementing optimal management of inpatient and outpatient hyperglycemia, creating protocols for inpatient hospital guidelines, identifying biomarkers to predict the development or progression of diabetic complications, detecting the earliest stages of complications to prevent progression of diseases, and developing sensitive diagnostic methods/treatment for those complications. Dr. Ang also serves as a Co-Director of Hospital Intensive Insulin Program. Dr. Ang has been actively involving in teaching internal medicine and podiatry residents, endocrinology fellows, and medical students in both ambulatory and inpatient clinical settings. She was a recipient of Goran Sundkvist Young Investigators Award for Clinical Science 2022. Dr. Ang is rated as an Advanced provider by MediFind in the treatment of Infant Hyperglycemia. Her top areas of expertise are Type 1 Diabetes (T1D), Diabetic Neuropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Nazanene H. Esfandiari, MD, is a Clinical Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes (MEND). Dr. Esfandiari received her medical degree from the University of Bordeaux in France, completed internal medicine residency in France and at UMASS Memorial Health Center in Massachusetts, and then completed fellowship in endocrinology at the University of Michigan. She joined the faculty at the University of Michigan in 2003. She was inducted into Clinical Excellence Society at the University of Michigan in 2014. She is the MEND Service Chief, Co-director of Hospital Intensive Insulin Program (HIIP) and Assistant Chief for the Inpatient Endocrine Consult.Dr. Esfandiari’s practice focuses on thyroid cancer, thyroid disorders, post bariatric care, and diabetes. She is also interested in medical education and is the Co-director of the Endocrine Sequence at the University of Michigan Medical School. In addition, Dr. Esfandiari has served in several national committees at the Endocrine Society and American Thyroid Association (ATA). Dr. Esfandiari is rated as an Advanced provider by MediFind in the treatment of Infant Hyperglycemia. Her top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Gastric Bypass, and Thyroidectomy.

Yu Kuei Alex Lin is a Clinical Assistant Professor of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes (MEND). After earning his medical degree at Poznan University of Medical Sciences, Poland, he completed his Medicine Residency at Beth Israel Medical Center, NY, and Endocrinology fellowship at Cleveland Clinic, OH. Dr. Lin joined the faculty at Michigan in 2019.Dr. Lin is a clinical diabetes researcher with research focuses on characterizing hypoglycemia (including evaluating impaired awareness of hypoglycemia and unhelpful hypoglycemia beliefs and management behaviors and their associations with hypoglycemia developments) and devising and testing behavioral interventions for improving hypoglycemia self-management. Dr. Lin’s clinical practice focuses on diabetes and general endocrinology. Dr. Lin is rated as an Advanced provider by MediFind in the treatment of Infant Hyperglycemia. His top areas of expertise are Low Blood Sugar, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Pancreatectomy, and Islet Cell Transplantation.

Dr. Kraftson specializes in treating patients with excess weight/obesity in addition to seeing patients with general endocrinologic conditions. He was inducted into the Clinical Excellence Society in 2021. He is the Director of the Weight Navigation Program & the Director of the Post Bariatric Endocrinology Clinic. Dr. Kraftson's research, focuses on gaining a better understanding of delivering effective care for individuals with obesity. In addition to these interests, Dr. Kraftson is actively involved in medical education and is the Associate Program Director for the M.E.N.D. Endocrinology Fellowship. Dr. Kraftson is rated as an Experienced provider by MediFind in the treatment of Infant Hyperglycemia. His top areas of expertise are Obesity, Malnutrition, Type 2 Diabetes (T2D), Gastric Bypass, and Sleeve Gastrectomy.

Nevin Ajluni, M.D., joined the team at the Division of Metabolism, Endocrinology & Diabetes (MEND) after serving a two-year endocrinology fellowship in the Division. She is a part of the care team in the MEND Weight Management Program, where she works with obese individuals by applying cutting-edge research findings and novel clinical strategies. She is an honors graduate of the Wayne State University School of Medicine and completed her internship and residency in internal medicine at the McGaw Medical Center of Northwestern University before coming to the University of Michigan. Dr. Ajluni is rated as an Experienced provider by MediFind in the treatment of Infant Hyperglycemia. Her top areas of expertise are Type 1 Diabetes (T1D), Familial Partial Lipodystrophy, Type 2 Diabetes (T2D), and Congenital Generalized Lipodystrophy.

Dr. Elif Oral is a professor in the Division of Metabolism, Endocrinology and Diabetes (MEND) at the University of Michigan. She completed her medical education in her home country of Turkey at the University of Istanbul. In 1996, she completed her residency in Internal Medicine at Sinai Hospital Detroit (Michigan). She then completed a fellowship in Endocrinology, Metabolism and Diabetes at the National Institute of Health, where she also chose to stay as a Senior Fellow under the mentorship of Drs SimeonTaylor and Phillip Gorden in in the Diabetes Branch of NIDDK.Since joining the University of Michigan in 2002 as an Assistant Professor of Medicine, along with her regular faculty responsibilities, Dr. Oral also completed a Masters of Science Degree in Clinical Research Design and Biostatistics at the School of Public Health. Her clinical interests are in insulin resistance, obesity, lipid disorders, and diabetes.Dr Oral's research focuses on the importance of adipocytes in human metabolism and adipocyte hormones such as leptin. She is best known for her work showing the remarkable efficacy of leptin in rare lipodystrophy syndromes. Metreleptin received approval by the FDA (2014) and EMA (2016) as a treatment for lipodystrophy owing to a large part to her original vision and work. These studies provided the basis for her current work with three big goals: identification of novel metabolic diseases, discovery of new disease mechanisms and finding treatments for patients afflicted with these disorders. In addition to her roles as physician, educator, and researcher, Dr Oral is also the director of two programs at MEND: Atypical Diabetes Program and Obesity and Metabolic Disorders Program. She directed the Post-Bariatric Surgery Care Program from 2012 to 2021 and continues to conduct research on the cohort of patients who had bariatric surgery performed in the Michigan Bariatric Surgery program. Dr. Oral is rated as an Experienced provider by MediFind in the treatment of Infant Hyperglycemia. Her top areas of expertise are Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, Gastric Bypass, and Sleeve Gastrectomy.

As director of the Michigan Metabolomics and Obesity Center, Dr. Charles F. Burant facilitates the network of obesity related researchers on the U-M campus which results in enhancing collaborative studies and speeding the translation of basic science findings into clinically useful therapies for metabolic diseases including obesity, Type 2 diabetes and related metabolic disorders.Dr. Burant earned both his medical degree and doctorate of philosophy in molecular and cellular biology from the Medical University of South Carolina in Charleston. His internship and residency were served at the University of California, San Francisco, and he completed his fellowship in the Department of Medicine, Endocrinology Section at the University of Chicago. He joined the University of Michigan faculty in 1999. Dr. Burant is rated as an Experienced provider by MediFind in the treatment of Infant Hyperglycemia. His top areas of expertise are Obesity, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D).

Dr. Chun is a physician-scientist, who practices general endocrinology, including diabetes, thyroid diseases, and metabolic syndrome. His research is focused on the cellular and molecular mechanism of obesity, diabetes, and inflammatory and fibrotic tissue damages in endocrine disorders, such as Graves’ eye disease. Dr. Chun is rated as an Experienced provider by MediFind in the treatment of Infant Hyperglycemia. His top areas of expertise are Hyperparathyroidism, Neonatal Severe Hyperparathyroidism, Osteitis Fibrosa, and Familial Isolated Hyperparathyroidism.

Preethi Gogineni is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Gogineni has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Infant Hyperglycemia. Her top areas of expertise are Hyperparathyroidism, Type 1 Diabetes (T1D), Gestational Diabetes, and Osteoporosis.

Jennifer Franzese is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Franzese is rated as an Experienced provider by MediFind in the treatment of Infant Hyperglycemia. Her top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, and Thyroid Nodule.

Jennifer Iyengar is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Iyengar is rated as an Experienced provider by MediFind in the treatment of Infant Hyperglycemia. Her top areas of expertise are Type 1 Diabetes (T1D), Thyroid Nodule, Paget's Disease of Bone, and Type 2 Diabetes (T2D).

Megan R. Haymart, MD is Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan. She holds the Nancy Wigginton Endocrinology Research Professorship of Thyroid Cancer and is Director of Thyroid Cancer Research at the University of Michigan. Dr. Haymart received her medical degree at Johns Hopkins University School of Medicine and completed her internal medicine residency at Johns Hopkins Hospital. She then completed a fellowship in endocrinology, diabetes, and metabolism at the University of Wisconsin. She has been faculty at the University of Michigan since 2009.Dr. Haymart has a history of NIH-funded research focused on optimizing thyroid care delivery. She is a health services researcher who primarily studies thyroid cancer care across the disease continuum: from the diagnosis of a thyroid nodule to cancer survivorship. In recognition of her research, she received the American Thyroid Association’s Van Meter Award for outstanding contributions to research on the thyroid gland (2017), the University of Michigan’s Jerome Conn Award for Research Excellence (2017), membership to American Society for Clinical Investigation (2018), the AACE Hossein Gharib Education Lectureship Award for exemplary contributions to an individual profession or area of expertise (2021), and the inaugural AACE Endocrine Care Innovation Award in recognition of her team’s outstanding body of work focused on clinical outcomes or health care delivery (2025).Dr. Haymart is actively involved in improving research infrastructure at the University of Michigan. This includes her roles as Assistant Director of Data Solutions for AI & Digital Health Innovation, faculty support for MICHR, and co-Director of Patient’s First. She also devotes time to mentoring junior faculty and trainees resulting in her receipt of the MICHR Distinguished Clinical and Translational Research Mentor Award (2021) and the Women in Thyroidology and American Thyroid Association Woman of the Year Award (2021) for promoting the advancement of women, both within the organization and field. Dr. Haymart is rated as an Experienced provider by MediFind in the treatment of Infant Hyperglycemia. Her top areas of expertise are Thyroid Cancer, Thyroid Nodule, Papillary Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT).

Farah Daneshvar, DO is a Clinical Assistant Professor in the Division of Metabolism, Endocrinology and Diabetes. Dr. Daneshvar received her bachelor's degree from University of Michgian (Ann Arbor, MI) and her medical degree from Michigan State University (Lansing, MI). She completed both her internal medicine residency and chief residency at Sinai Grace Hospital/Detroit Medical Center (Detroit, MI) and then underwent fellowship training in endocrinology at the University of Washington (Seattle, WA).Dr. Daneshvar is involved in medical eduation including medical students, residents, and fellows. She is the preceptor for Fellows’ Clinic for Endocrinology Fellowship Program at the University of Michigan. Dr. Daneshvar is rated as an Advanced provider by MediFind in the treatment of Infant Hyperglycemia. Her top areas of expertise are Type 2 Diabetes (T2D), Pituitary Tumor, Prolactinoma, and Exogenous Cushing's syndrome.

Sima Saberi is an Endocrinologist in Ann Arbor, Michigan. Dr. Saberi is rated as an Experienced provider by MediFind in the treatment of Infant Hyperglycemia. Her top areas of expertise are Type 2 Diabetes (T2D), Diabetic Nephropathy, Type 1 Diabetes (T1D), Osteoporosis, and Thyroidectomy.

Noura Nachawi is an Endocrinologist in Ann Arbor, Michigan. Dr. Nachawi has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Infant Hyperglycemia. Her top areas of expertise are Hypercalcemia, Milk-Alkali Syndrome, Low Blood Sugar, and Hyperparathyroidism.

Jessie King is a primary care provider, practicing in Internal Medicine and Hospital Medicine in Ann Arbor, Michigan. Dr. King is rated as an Experienced provider by MediFind in the treatment of Infant Hyperglycemia. Her top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Aplastic Anemia, Bone Marrow Aspiration, and Endoscopy.

Dr. Fine is an honors graduate of Harvard University and the U-M Medical School. He completed his internal medicine residency and served as chief medical resident at the U-M Medical Center. Dr. Fine was cited recently in The Best Doctors in America: Midwest Edition, 2017-2018. He enjoys piano and poetry composition, reading and music.Read Dr. Fine's 8 questions profile. Dr. Fine is rated as an Experienced provider by MediFind in the treatment of Infant Hyperglycemia. His top areas of expertise are Sickle Cell Disease, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Colonoscopy, and Balloon Sinuplasty.

Dr. Patel is a graduate of Wayne State University School of Medicine and completed his internal medicine residency at Henry Ford Hospital in Detroit. He speaks English and Gujarati. *He enjoys aerobics and running. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Infant Hyperglycemia. His top areas of expertise are Maturity Onset Diabetes of the Young, Lupus Nephritis, Type 2 Diabetes (T2D), and Glucocorticoid-Remediable Aldosteronism.

Martha Gray is a primary care provider, practicing in Geriatrics in Ann Arbor, Michigan. Dr. Gray is rated as an Experienced provider by MediFind in the treatment of Infant Hyperglycemia. Her top areas of expertise are Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Breast Cancer.

Sobia Raja is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Raja is rated as an Experienced provider by MediFind in the treatment of Infant Hyperglycemia. Her top areas of expertise are Osteoporosis, Thyroid Nodule, Hypoaldosteronism, Endoscopy, and Hip Replacement.